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metric show a somewhat larger influence of the calculation 
algorithm used compared to the edge area metric. 
 
Conclusion: Different dose calculation algorithms can 
influence on the correlation between aperture-based 
complexity metric scores and complexity of the treatment 
field. The impact is different for different metrics. 
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Purpose or Objective: To evaluate the feasibility and the 
safety of delivering intraoperative radiotherapy (ELIOT) to 
the tumor bed in breast cancer patients withcardiac 
implantable electronical devices as part of breast 
conservative treatment. Cardiac devices, as pacemakers or 
defibrillators, can suffer from malfunctions as a result of 
exposure to ionizing radiation. Scattered radiation can be 
harmful as direct radiation as well. Measurements of 
absorbed dose during ELIOT in the subclavicular region 
supposed to house cardiac implantable electronical devices 
were carried out in healthy patients without heart disease. 
The aim of the study is to verify that the intraoperative dose 
does not exceed the recommended maximum dose of 2 Gy. 
 
Material and Methods: The present analysis was performed 
on 18 out of 25 patients considered for the study. After 
signing the informed consent, all patients underwent breast 
conserving surgery. After tumor removal and before 
delivering ELIOT to the tumor bed, two catheters, each of 
them containing 8 thermoluminescent dosimeters (TLDs), 
were placed. The first catheter, the internal one, was 
attached to the thoracic shielding (an aluminum–lead disk of 
7-8 cm in diameter) and became an integral part of it. The 
shielding was located beneath the reconstructed breast 
parenchyma of the tumor bed, to minimize the dose to 
underlying tissues and its tip was positioned in the 
subclavicular region, where cardiac devices are supposed to 
be. The second catheter, the external one, was placed on the 
skin, parallel to the first one, next to the applicator (4-5 cm 
of diameter, flat or 15° beveled). The TLD reading showed 
the absorbed dose due to the scattered dose correlated to 
the distance from the applicator. 
 
Results: Given a prescribed dose of 21 Gy at 90% isodose, the 
external TLDs on the skin read a mean dose of 0.32 Gy 
(range, 0.10 – 0.55 Gy), measured starting 1.5 cm from the 
applicator wall up to 10.5 cm. By evaluating the doses 
measured by TLDs in the internal catheter, the minimum 
distance considered safe for cardiac devices was found to be 
2.5 cm from the applicator wall. In fact, at that distance, the 
cumulative scatter radiation dose was lower than 2 Gy. 
Comparing the data from the two catheters, higher doses 
were measured in the internal catheter compared to the 
external one. Therefore, the main source of scattered dose 
was the patient herself rather than the mobile accelerator. 
 
Conclusion: Final results are not available yet, as the study is 
ongoing. However, on the basis of analyzed data, ELIOT 
seems to be safe for patients using cardiac devices as long as 
the minimum distance of 2.5 cm is kept between the cardiac 
device edge and the applicator wall. No correlation with 
tumor site and electron energy was observed. When clinically 
indicated, ELIOT might be a valid alternative to external 
irradiation, which is conditioned by the low threshold dose 
for cardiac devices, as recommended by current guidelines. 
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Purpose or Objective: The in-air output ratio (Sc), describes 
how the photon fluence per monitor unit varies with beam 
collimator settings. In this study, the contribution from 
different accelerator head components to the total Sc was 
investigated for fields generated with and without a 
flattening filter in the beam line. 
 
Material and Methods: Using the EGSnrc-package, a Monte 
Carlo model of the accelerator head of an Elekta Synergy 
linac has been built and verified with measured lateral and 
depth-dose profiles. Four different energy/filter 
combinations were simulated, one conventional 6 MV beam 
with a flattening filter (FF), two flattening filter-free (FFF) 
beams where the flattening filter was replaced by a 2 mm 
thick iron plate and the incident electron energy was kept 
the same as for the FF beam or increased to produce a 
similar depth-dose curve as the FF beam, and one untuned 
beam without any filter in the beam line. Sc was calculated 
as the ratio of primary collision water kerma (Kp) for any 
collimator setting to a reference collimator setting (10×10 
cm²) for the same number of monitor units as defined in Zhu 
et al. (Med Phys 36 5261-91, 2009). Kp was derived from a 
photon spectra scored in air in a circular region with a radius 
of 0.5 cm centred on the central axis 100 cm from the target 
for collimator settings ranging from 3×3 cm² to 40×40 cm². 
The contributions from different parts of the accelerator 
were evaluated using the LATCH variable. The calculated Sc 
was compared to measurements performed with a farmer ion 
chamber with a 2.5 mm brass build-up cap. 
 
Results: Calculated Sc were within 0.4 % of measured values 
for both FF and the energy matched FFF beam. Unscattered 
photons, i.e. photons only interacting in the target, were, as 
expected, found to be invariant relative to the reference 
field and accounted for 98 % and 92 % of the total Sc for the 
conventional FF beam, for the 3×3 cm² and 40×40 cm² fields, 
respectively. For the FFF beams this proportion was 
increased to 99 % and 96 % for the untuned beam and to 99 % 
and 97 % for both the tuned FFF and the beam without metal 
plate (Fig 1). For the FF beam, photons having interacted in 
the flattening filter are the major contributors to the 
variation in Sc for fields larger than 10×10 cm², while for 
smaller fields the contribution from photons interacting in 
the primary collimator have an equal or slightly larger 
impact. However, for the FFF beams, photons interacting in 
the primary collimator are the largest contributors to Sc for 
all field sizes and the difference in contribution from the 
metal plate (if any) and secondary collimators are within the 
uncertainty of the calculated values. 
 
 
 
 
